Study patients (n = 259)

Age, yrs, mean ± SD

76.6 ± 8.5

Sex ratio (male/female)

125:134

Disease duration, yrs

6.2 ± 5.1

Observation period, wks, median (range)

54 (0 - 105)

Underlying disease

PD (n)

220 (84.9%)

H-Y stage, mean ± SD

3.1 ± 1.0

PSP, n (%)

29 (11.2%)

MSA, n (%)

7 (2.7%)

CBS, n (%)

3 (1.2%)

Subjects who interrupted, n (%)

PD, n (%)

PSP, n (%)

MSA, n (%)

CBS, n (%)

Period until interruption, wks (range)

Subjects who restarted

PD, n (%)

PSP, n (%)

MSA, n (%)

CBS, n (%)

Period until restart, wks, median (range)s

133 (51.4%)

109/220 (49.5%)

17/29 (58.6%)

5/7 (71.4%)

2/3 (66.7%)

39 (0 - 104)

29 (21.8%)

26/109 (23.9%)

1/17 (5.9%)

0/5 (0%)

2/2 (100%)

10 (2 - 40)